BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/19/2014 3:06:00 PM | Browse: 894 | Download: 917
Publication Name World Journal of Immunology
Manuscript ID 10385
Country Japan
Received
2014-03-29 11:40
Peer-Review Started
2014-03-31 14:41
To Make the First Decision
2014-04-15 15:17
Return for Revision
2014-04-16 14:11
Revised
2014-05-14 21:09
Second Decision
2014-09-10 09:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-09-10 09:45
Articles in Press
2014-09-10 09:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-11-11 16:39
Publish the Manuscript Online
2014-11-19 15:06
ISSN 2219-2824 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Allergy
Manuscript Type Review
Article Title Transgenic plants for allergen-specific immunotherapy
Manuscript Source Invited Manuscript
All Author List Tomoe Nishimura, Mayumi Saeki, Osamu Kaminuma, Fumio Takaiwa and Takachika Hiroi
Funding Agency and Grant Number
Funding Agency Grant Number
Grant-in-Aid for Agri-health Project from the Ministry of Agriculture, Forestry and Fisheries of Japan (to Takaiwa F and Hiroi T)
JSPS KAKENHI 24791817( to Saeki M)
JSPS KAKENHI 26860122 (to Saeki M)
JSPS KAKENHI 24500501 (to Kaminuma O)
Grant-in-Aid of Mishima Kaiun Memorial Foundation (to Kaminuma O)
Corresponding Author Takachika Hiroi, DDS, PhD, Allergy and Immunology Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan. hiroi-tk@igakuken.or.jp
Key Words Allergic disease; Asthma; Oral immunotherapy; Rhinitis; Transgenic rice
Core Tip We aim to establish clinically applicable oral immunotherapy (IT) by employing transgenic rice seeds (Tg rice) in which allergen epitopes are expressed. We have identified a suitable allergen packaging system, modified allergens to reduce their allergenicity, selected high allergen-producing lines, and evaluated their efficacy in allergic disease models. We are thus nearly ready to start clinical trials of our Tg rice for the treatment of Japanese cedar pollinosis.
Publish Date 2014-11-19 15:06
Citation Nishimura T, Saeki M, Kaminuma O, Takaiwa F, Hiroi T. Transgenic plants for allergen-specific immunotherapy. World J Immunol 2014; 4(3): 141-148
URL http://www.wjgnet.com/2219-2824/full/v4/i3/141.htm
DOI http://dx.doi.org/10.5411/wji.v4.i3.141
Full Article (PDF) WJI-4-141.pdf
Full Article (Word) WJI-4-141.doc
Manuscript File 10385-Review.doc
Answering Reviewers 10385-Answering reviewers.pdf
Copyright License Agreement 10385-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 10385-Language certificate.docx
Peer-review Report 10385-Peer review(s).pdf
Scientific Misconduct Check 10385-CrossCheck.jpg
Scientific Editor Work List 10385-Scientific editor work list.pdf